FXN and Ataxia: Collaborative work such as the European Friedreich’s Ataxia Consortium for Translational studies (EFACTS) [26–28], and the Friedreich’s Ataxia Clinical Outcome Measures (FACOMS) [34, 35] helped evaluate longitudinal changes in clinical assessment tools and develop assays to measure blood frataxin.